Novo Nordisk A/S
Save
–
Market cap
47.2x
Current P/E
39.37x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas.
Similar securities
Based on sector and market capitalization
Report issue